CJC-1295 without DAC (mod GRF 1-29) has a half-life of roughly 30 minutes, producing brief but intense GH pulses especially when paired with a GHRP like ipamorelin
This finding would indicate that TC progression could be prevented and these genes could be selected as therapeutic targets (Ozdemir Kutbay et al., 2020)
Before their application in clinical practice, further studies are needed to verify their safety and effectiveness, and reasonable ethical and legal norms should be formulated to guide the clinical use of EVs
This is a one-time investment that pays for itself across multiple protocols
Bourne C, Aydemir O, Balanza-Martinez V, Bora E, Brissos S, Cavanagh JT, et al
[5] At equivalent GH-stimulating doses, ipamorelin's selectivity profile is superior to GHRP-2 for research designs where GH-specific signaling is the goal